Acorda Therapeutics Inc ACOR released its results for the second quarter on Monday.
Acorda Therapeutics reported its quarterly earnings at $0.01 per share. ACOR's revenue climbed 52.6% y/y to $65.3 million. Analysts were expecting earnings of $0.12 per share on revenue of $66.04 million.
Acorda Therapeutics shares gained 0.46% to close at $28.40 on Friday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in